Related references
Note: Only part of the references are listed.Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update
Yun-Fan Liaw et al.
HEPATOLOGY INTERNATIONAL (2012)
EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection
George Papatheodoridis et al.
JOURNAL OF HEPATOLOGY (2012)
Lifetime Risk and Sex Difference of Hepatocellular Carcinoma Among Patients With Chronic Hepatitis B and C
Yen-Tsung Huang et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Long-Term Effect of Interferon Plus Ribavirin on Hepatitis B Surface Antigen Seroclearance in Patients Dually Infected with Hepatitis B and C Viruses
Ming-Lun Yeh et al.
PLOS ONE (2011)
A Sustained Virologic Response Is Durable in Patients With Chronic Hepatitis C Treated With Peginterferon Alfa-2a and Ribavirin
Mark G. Swain et al.
GASTROENTEROLOGY (2010)
HBsAg Profiles in Patients Receiving Peginterferon Alfa-2a plus Ribavirin for the Treatment of Dual Chronic Infection with Hepatitis B and C Viruses
Ming-Lung Yu et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Peginterferon Alfa-2a Plus Ribavirin for the Treatment of Dual Chronic Infection With Hepatitis B and C Viruses
Chun-Jen Liu et al.
GASTROENTEROLOGY (2009)
Dual chronic hepatitis B virus and hepatitis C virus infection
Chun-Jen Liu et al.
HEPATOLOGY INTERNATIONAL (2009)
Entecavir therapy for up to 96 weeks in patients with HBeAg-Positive chronic hepatitis B
Robert G. Gish et al.
GASTROENTEROLOGY (2007)
HBsAg seroclearance in asymptomatic carriers of high endemic areas: Appreciably high rates during a long-term follow-up
Chia-Ming Chu et al.
HEPATOLOGY (2007)
Peginterferon alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B
GKK Lau et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B
P Marcellin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Influence of chronic coinfection with hepatitis B and C virus on liver histology
E Sagnelli et al.
INFECTION (2004)
Incidence and cofactors of hepatitis C virus-related hepatocellular carcinoma: A prospective study of 12,008 men in Taiwan
CA Sun et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2003)
A severe hepatitis flare in an HBV-HCV coinfected patient during combination therapy with alpha-interferon and ribavirin
K Yalcin et al.
JOURNAL OF GASTROENTEROLOGY (2003)
HBV superinfection in hepatitis C virus chronic carriers, viral interaction, and clinical course
E Sagnelli et al.
HEPATOLOGY (2002)
Extended follow-up of anti-HBe-positive chronic hepatitis B retreated with ribavirin patients with and interferon-α
V Carreño et al.
ANTIVIRAL RESEARCH (2001)
Share Paper
